LAMPS as DDT for Hepatotoxicity Submitted to CDER ISTAND

A letter of intent for the LAMPS as a DDT to establish the hepatotoxicity of drug candidates in patients with MASLD and assist in the determination of drug candidate dosing in clinical trials when patients with MASLD are included has been submitted and determined to be reviewable by the CDER ISTAND pilot program for qualification. – July 3, 2025.